Synchrony Financial filings document the regulatory record of a consumer finance company with common stock and preferred depositary shares listed on the New York Stock Exchange. Its Form 8-K reports include quarterly earnings releases, financial data supplements, presentations and monthly charge-off and delinquency statistics tied to the company’s credit portfolio.
The company’s proxy materials cover annual meeting matters, director elections, auditor ratification and advisory executive compensation votes. Other filings describe capital-structure activity, including public debt offerings under shelf registration statements, senior note indenture terms, preferred stock series and related exhibits.
Synchrony Financial executive Darrell Owens reported equity compensation activity involving company common stock. On January 21, 2026, he acquired 15,213 shares of Synchrony Financial common stock at $77.13 per share, earned upon vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-established performance goals.
The company withheld 4,909 shares at $77.13 per share to cover Owens’ tax liability related to the PSU vesting. After these transactions, Owens directly held 26,469 shares of Synchrony Financial common stock in his capacity as EVP & CEO--Lifestyle.
Synchrony Financial executive Jonathan S. Mothner, EVP and Chief Risk and Legal Officer, reported stock transactions tied to long-term incentives. On January 21, 2026, he acquired 63,444 shares of Synchrony common stock at $77.13 per share, earned through the vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-set performance goals. On the same date, 29,487 shares were withheld by the company at the same price to cover his tax obligations from this vesting. After these transactions, he directly owned 161,057 shares of Synchrony common stock.
Synchrony Financial EVP Alberto Casellas reported equity compensation activity involving company common stock. On January 21, 2026, he acquired 67,590 shares of Synchrony Financial common stock at $77.13 per share, earned through the vesting of Performance Share Units under the 2023–2025 Long-Term Performance Program based on pre-established performance goals.
On the same date, 31,870 shares were withheld by the company at $77.13 per share to cover his tax liability from the PSU vesting. After these transactions, Casellas directly owned 92,850 shares of Synchrony Financial common stock in his capacity as EVP, CEO–Health & Wellness.
Synchrony Financial executive equity award activity: EVP, Chief Technology and Operating Officer Carol Juel reported stock transactions tied to long-term incentive compensation. On 01/21/2026, she acquired 79,305 shares of Synchrony common stock, earned upon vesting of Performance Share Units under the 2023-2025 Long-Term Performance Program based on pre-established performance goals. On the same date, 34,894 shares were withheld by the company to cover her tax liability related to this vesting. After these transactions, she held 102,941 shares of Synchrony common stock directly.
Synchrony Financial reported that one of its directors received a new equity grant in the form of restricted stock units. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock at a price of $83.43 per share, increasing the director’s beneficial ownership to 32,775 shares held directly after the transaction.
The award is structured as restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock, meaning the director must satisfy the vesting conditions before receiving the underlying shares.
Synchrony Financial reported an equity award to one of its directors. On 12/31/2025, the director acquired 660 shares of Synchrony Financial common stock at a price of $83.43 per share, reported as an acquisition of common stock. An accompanying note explains that this represents restricted stock units that will vest in full on December 31, 2026, with each unit converting into one share of common stock at vesting. After this transaction, the director beneficially owned 28,562 shares directly and 15,300 shares indirectly through family trusts.
Synchrony Financial director reports equity award in Form 4 filing. A board member received 660 shares of Synchrony Financial common stock on December 31, 2025 at a price of $83.43 per share, reported as an acquisition. After this transaction, the director beneficially owns 49,755 shares directly.
The award is in the form of restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock, so the director’s actual share ownership will increase as these units vest.
Synchrony Financial reported an equity award to one of its directors. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock in the form of restricted stock units at a reference price of $83.43 per share. After this transaction, the director beneficially owns 3,972 shares of common stock directly.
The 660 restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of Synchrony Financial common stock. This filing reflects a routine director equity grant rather than an open-market stock purchase or sale.
Synchrony Financial director reported receiving a grant of restricted stock units. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock in the form of restricted stock units at a reference price of $83.43 per share. Following this transaction, the director beneficially owns 660 shares directly. The filing notes that these restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of common stock.
Synchrony Financial director reports new stock award. A company director filed details of a stock-based compensation grant involving Synchrony Financial common stock. On 12/31/2025, the director acquired 660 shares in the form of restricted stock units at a value of $83.43 per share. After this grant, the director beneficially owns 16,218 shares of Synchrony Financial common stock in direct ownership.
The filing notes that these 660 restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of Synchrony Financial common stock.